Janney Montgomery Scott LLC increased its position in shares of Zoetis Inc (NYSE:ZTS) by 4.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,576 shares of the company’s stock after acquiring an additional 4,927 shares during the period. Janney Montgomery Scott LLC’s holdings in Zoetis were worth $6,795,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ZTS. Northwestern Mutual Wealth Management Co. raised its position in Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock valued at $100,000 after purchasing an additional 230 shares in the last quarter. Harfst & Associates Inc. raised its position in Zoetis by 16.1% in the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock valued at $117,000 after purchasing an additional 260 shares in the last quarter. Almanack Investment Partners LLC. acquired a new stake in Zoetis in the 2nd quarter valued at about $119,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in Zoetis by 251.9% in the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock valued at $121,000 after purchasing an additional 1,360 shares in the last quarter. Finally, Peddock Capital Advisors LLC acquired a new stake in Zoetis in the 2nd quarter valued at about $140,000. 93.33% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have issued reports on the company. Cantor Fitzgerald set a $80.00 price target on Zoetis and gave the company a “buy” rating in a research report on Tuesday. Morgan Stanley raised Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price target on the stock in a research report on Wednesday, November 29th. UBS reaffirmed a “neutral” rating on shares of Zoetis in a research report on Friday, November 24th. Cowen set a $80.00 price target on Zoetis and gave the company a “buy” rating in a research report on Friday, November 17th. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Zoetis in a research report on Friday, November 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $68.53.

Zoetis Inc (NYSE ZTS) traded up $0.46 on Wednesday, hitting $72.23. The stock had a trading volume of 1,939,800 shares, compared to its average volume of 2,757,257. Zoetis Inc has a fifty-two week low of $50.57 and a fifty-two week high of $72.79. The stock has a market cap of $34,972.68, a P/E ratio of 32.92, a P/E/G ratio of 2.15 and a beta of 1.06. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, November 2nd. The company reported $0.65 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.02. Zoetis had a return on equity of 62.39% and a net margin of 18.29%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the prior year, the business posted $0.52 EPS. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. analysts forecast that Zoetis Inc will post 2.37 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Friday, January 19th will be issued a $0.126 dividend. The ex-dividend date is Thursday, January 18th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.70%. This is an increase from Zoetis’s previous quarterly dividend of $0.11. Zoetis’s dividend payout ratio is presently 22.11%.

WARNING: “Janney Montgomery Scott LLC Boosts Position in Zoetis Inc (ZTS)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/13/janney-montgomery-scott-llc-boosts-position-in-zoetis-inc-zts.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Stock Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related stocks with our FREE daily email newsletter.